Prevalence of RAS mutations in gynecologic cancers by histology for (a) NRAS and (b) HRAS. In parentheses, mut (n)/histology (n)
No takes yet. Share an insight, caveat, or question.
Son et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: